Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abatacept”

213 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 213 results

Large-scale testing (Phase 3)Study completedNCT02067910
What this trial is testing

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
University Medical Center Groningen 80
Testing effectiveness (Phase 2)Study completedNCT03669861
What this trial is testing

Safety and Efficacy of Abatacept in IgG4-Related Disease

Who this might be right for
IgG4-related Disease
Massachusetts General Hospital 10
Not applicableStudy completedNCT04343378
What this trial is testing

Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
University Hospital, Rouen 40
Testing effectiveness (Phase 2)Study completedNCT02161406
What this trial is testing

Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna, MD, MS 88
Testing effectiveness (Phase 2)Study completedNCT03680092
What this trial is testing

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

Who this might be right for
GVHDHematologic Neoplasms
Dimitrios Tzachanis, MD PhD 43
Large-scale testing (Phase 3)Study completedNCT00048932
What this trial is testing

A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,795
Testing effectiveness (Phase 2)Ended earlyNCT00035529
What this trial is testing

Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Bristol-Myers Squibb
Large-scale testing (Phase 3)Looking for participantsNCT05335928
What this trial is testing

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Who this might be right for
Myocarditis AcuteCancer
Massachusetts General Hospital 390
Testing effectiveness (Phase 2)Looking for participantsNCT05917522
What this trial is testing

Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

Who this might be right for
Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 800
Post-approval studies (Phase 4)Study completedNCT03652961
What this trial is testing

Rheumatoid Arthritis Memory B Cells and Abatacept

Who this might be right for
Rheumatoid Arthritis
NYU Langone Health 25
Large-scale testing (Phase 3)UnknownNCT03632187
What this trial is testing

Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS

Who this might be right for
Polymyalgia Rheumatica
University Hospital, Brest 34
Testing effectiveness (Phase 2)Study completedNCT02592798
What this trial is testing

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

Who this might be right for
Nephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease
Bristol-Myers Squibb 36
Early research (Phase 1)Study completedNCT00279734
What this trial is testing

Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 80
Not applicableStudy completedNCT03466814
What this trial is testing

Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Origin

Who this might be right for
Undifferentiated Arthritis
Bristol-Myers Squibb 82
Testing effectiveness (Phase 2)Study completedNCT03215927
What this trial is testing

Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease

Who this might be right for
MyositisInterstitial Lung Disease
Rohit Aggarwal, MD 20
Testing effectiveness (Phase 2)Study completedNCT00162266
What this trial is testing

Abatacept With Methotrexate- Phase IIB

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 524
Large-scale testing (Phase 3)UnknownNCT02722694
What this trial is testing

Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis (RA)
Jiangsu Simcere Pharmaceutical Co., Ltd. 360
Not applicableStudy completedNCT03457792
What this trial is testing

Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 158
Testing effectiveness (Phase 2)Study completedNCT00119678
What this trial is testing

Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 183
Testing effectiveness (Phase 2)Study completedNCT01743131
What this trial is testing

Abatacept as GVHD Prophylaxis Phase 2

Who this might be right for
Graft vs Host DiseaseMalignancy
Boston Children's Hospital 186
Load More Results